Jurisdiction - China
Skadden Advises Chindex on Acquisistion by TPG and Fosun Pharma.

18 February, 2014


Skadden is advising on the approximately US$369m pending going-private transaction of Chindex International, Inc. (“Chindex”), an American healthcare company providing services in China through the premium hospital and ambulatory clinic operations of United Family Healthcare, by a buyer consortium consisting of an affiliate of TPG and an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 


Skadden is representing Ms. Roberta Lipson, the CEO of Chindex, who is rolling a substantial portion of her equity in Chindex, and other members of senior management. The team includes mergers and acquisitions partners Jon Christianson, Peter Huang and Daniel Dusek; executive compensation and benefits partner Joseph Yaffe; and commercial litigation partner Eric Waxman.


Conventus Law

Follow us on Twitter @conventuslaw

Comments are closed.